
Download Files:
Cys-mcMMAD
SKU
HY-15750-1 mg
Category ADC Related
Tags Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage;Cytoskeleton, Cancer, Drug-Linker Conjugates for ADC;Microtubule/Tubulin
$1,200 – $3,000
Products Details
Product Description
– Cys-mcMMAD is a agent-linker conjugate for ADC. MMAD is a potent tubulin inhibitor.
Web ID
– HY-15750
Storage Temperature
– -20°C (Powder, protect from light)
Shipping
– Blue Ice
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C54H84N8O11S2
References
– [1]Antibody-drug conjugates Patent: WO 2013068874 A1
Molecular Weight
– 1085.42
Compound Purity
– 98.77
SMILES
– CC[C@H](C)[C@@H]([C@@H](CC(N1[C@@H](CCC1)[C@@H]([C@@H](C)C(N[C@H](C2=NC=CS2)CC3=CC=CC=C3)=O)OC)=O)OC)N(C([C@H](C(C)C)NC([C@H](C(C)C)N(C(CCCCCN4C(CC(SC[C@@H](C(O)=O)N)C4=O)=O)=O)C)=O)=O)C
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– DMSO : 200 mg/mL (ultrasonic)
Target
– Drug-Linker Conjugates for ADC;Microtubule/Tubulin
Isoform
– Auristatin
Pathway
– Antibody-drug Conjugate/ADC Related;Cell Cycle/DNA Damage;Cytoskeleton
Product type
– ADC Related
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.